AU7903100A - Peptide mixture and vaccine against a chronic viral infection - Google Patents

Peptide mixture and vaccine against a chronic viral infection

Info

Publication number
AU7903100A
AU7903100A AU79031/00A AU7903100A AU7903100A AU 7903100 A AU7903100 A AU 7903100A AU 79031/00 A AU79031/00 A AU 79031/00A AU 7903100 A AU7903100 A AU 7903100A AU 7903100 A AU7903100 A AU 7903100A
Authority
AU
Australia
Prior art keywords
viral infection
vaccine against
peptide mixture
chronic viral
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79031/00A
Inventor
Catharina Hultgren
Matti Sallberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro-Diagnostic AB
Original Assignee
Euro-Diagnostic AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Diagnostic AB filed Critical Euro-Diagnostic AB
Publication of AU7903100A publication Critical patent/AU7903100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU79031/00A 1999-08-27 2000-08-21 Peptide mixture and vaccine against a chronic viral infection Abandoned AU7903100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9903031 1999-08-27
SE9903031A SE9903031D0 (en) 1999-08-27 1999-08-27 Peptide mixture and vaccine against a chronic viral infection
PCT/EP2000/008124 WO2001016163A2 (en) 1999-08-27 2000-08-21 Peptide mixture and vaccine against a chronic viral infection

Publications (1)

Publication Number Publication Date
AU7903100A true AU7903100A (en) 2001-03-26

Family

ID=20416772

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79031/00A Abandoned AU7903100A (en) 1999-08-27 2000-08-21 Peptide mixture and vaccine against a chronic viral infection

Country Status (5)

Country Link
EP (1) EP1206278A2 (en)
JP (1) JP2003508409A (en)
AU (1) AU7903100A (en)
SE (1) SE9903031D0 (en)
WO (1) WO2001016163A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824326B1 (en) * 2001-05-04 2004-03-19 Commissariat Energie Atomique MIXTURE OF PEPTIDES FROM PAPILLOMAVIRUS E6 AND / OR E7 PROTEINS AND THEIR APPLICATIONS
US7351413B2 (en) 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
EP1638993A4 (en) * 2003-06-10 2007-05-09 Univ Melbourne Immunomodulating compositions, uses therefor and processes for their production
GB0608368D0 (en) * 2006-04-28 2006-06-07 Isis Innovation Process for making Oligopeptides
WO2008000261A2 (en) * 2006-06-28 2008-01-03 Statens Serum Institut Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
CA2697373C (en) 2007-08-27 2019-05-21 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2106803A1 (en) 2008-04-04 2009-10-07 Fondazione Centro San Raffaele del Monte Tabor Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
CN102060929A (en) * 2010-06-07 2011-05-18 夏书奇 T-cell immune balance peptide
AU2014361788B2 (en) * 2013-12-13 2019-10-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Multi-epitope TARP peptide vaccine and uses thereof
CN113950334A (en) * 2019-06-07 2022-01-18 俄勒冈健康与科学大学 Hepatitis B virus specific T cell response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
US6165730A (en) * 1992-03-06 2000-12-26 N.V. Innogenetics S.A. Hepatitis C virus peptides obtained from the NS4 coding region and their use in diagnostic assays
WO1996022067A2 (en) * 1994-12-27 1996-07-25 United Biomedical, Inc. Peptide ratchet libraries for ctl-inducing vaccines and therapeutics

Also Published As

Publication number Publication date
JP2003508409A (en) 2003-03-04
WO2001016163A2 (en) 2001-03-08
EP1206278A2 (en) 2002-05-22
SE9903031D0 (en) 1999-08-27
WO2001016163A3 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU6086300A (en) Recombinant envelope vaccine against flavivirus infection
AU7903100A (en) Peptide mixture and vaccine against a chronic viral infection
AU2002210450A1 (en) Maintaining virus detection software
AU4869299A (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
AU2001244188A1 (en) Medicaments against viral diseases
AU2001247902A1 (en) Cpg reduced plasmids and viral vectors
AU3834999A (en) Recombinant venezuelan equine encephalitis virus vaccine
AU1951201A (en) Peptide antigens
AU3328900A (en) Influenza virus hemagglutinin-binding peptides
AU2001271976A1 (en) Microspheres and adjuvants for dna vaccine delivery
EP1204424A4 (en) Recombinant rsv virus expression systems and vaccines
AU2002233457A1 (en) Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine
AU2001289831A1 (en) Medicaments against viral infections
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2003242222A1 (en) A recombinant anti-enveloped virus peptide and its preparation
AUPQ233799A0 (en) Recombinant sub-unit vaccine
AU2002220416A1 (en) Oncolytic virus
AU4415099A (en) Inhibition of viral infection and spread with viral and rhoa-derived peptides
AU4957800A (en) Vaccine against isa virus
AU2001252921A1 (en) A glycopeptide and preparation thereof
AU5520796A (en) Peptide-based vaccine against papillomavirus infection
AU2232399A (en) Recombinant ctb-based vaccines
AU5811600A (en) Vaccine
AU7684000A (en) Interferon complex and medicinal use thereof
AU2002213755A1 (en) A vaccine for acids and its preparation and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase